Cargando…
Afamin predicts gestational diabetes in polycystic ovary syndrome patients preconceptionally
BACKGROUND: Patients suffering from polycystic ovary syndrome (PCOS) are often insulin resistant and at elevated risk for developing gestational diabetes mellitus (GDM). The aim of this study was to explore afamin, which can be determined preconceptionally to indicate patients who will subsequently...
Autores principales: | Köninger, Angela, Iannaccone, Antonella, Hajder, Ensar, Frank, Mirjam, Schmidt, Boerge, Schleussner, Ekkehard, Kimmig, Rainer, Gellhaus, Alexandra, Dieplinger, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510713/ https://www.ncbi.nlm.nih.gov/pubmed/30991357 http://dx.doi.org/10.1530/EC-19-0064 |
Ejemplares similares
-
Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study
por: Köninger, Angela, et al.
Publicado: (2018) -
Afamin: an early predictor of preeclampsia
por: Köninger, Angela, et al.
Publicado: (2018) -
Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome
por: Köninger, Angela, et al.
Publicado: (2014) -
Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
por: Seeber, Beata, et al.
Publicado: (2014) -
Therapeutic Plasma Exchange in Early-Onset Preeclampsia: A 7-Year Monocentric Experience
por: Iannaccone, Antonella, et al.
Publicado: (2023)